Northwest Medical Specialties Hematology/Oncology — Tacoma, Washington

Northwest Medical Specialties Hematology/Oncology is a clinical research site located in Tacoma, Washington, United States 98405.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Northwest Medical Specialties Hematology/Oncology has participated in 2 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, PI3K Pathway Activated Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwest Medical Specialties Hematology/Oncology?

Northwest Medical Specialties Hematology/Oncology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwest Medical Specialties Hematology/Oncology conducted?

Northwest Medical Specialties Hematology/Oncology has 2 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, PI3K Pathway Activated Tumors.

Is Northwest Medical Specialties Hematology/Oncology accredited by Crixeo Health?

Northwest Medical Specialties Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwest Medical Specialties Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.